Skip to main content
Clinical Trials/NCT06692478
NCT06692478
Completed
Not Applicable

Benefits of Intrahospital Exercise Program in Pediatric Hematopoietic Stem Cell Transplant-A Randomized Control Trial

Phoenix Children's Hospital1 site in 1 country40 target enrollmentOctober 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hematopoietic Stem Cell Transplant
Sponsor
Phoenix Children's Hospital
Enrollment
40
Locations
1
Primary Endpoint
Change from Baseline 6-minute walk test at 6 weeks discharge.
Status
Completed
Last Updated
last year

Overview

Brief Summary

This randomized control study examines the effect of an intrahospital exercise regimen on the physical deconditioning that occurs due to hematopoietic stem cell transplant in the pediatric population.

Registry
clinicaltrials.gov
Start Date
October 1, 2017
End Date
October 1, 2019
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients ages 4-21 years of age who present for hematopoietic stem cell transplant.
  • Karnofsky (if ≥16 years) or Lansky (if \<16 years) score \>60 at enrollment and prior to each testing point
  • Parental/guardian permission (informed consent) and child assent prior to transplant.

Exclusion Criteria

  • Patients with any preexisting need for gait assistance such as crutches, wheelchair, braces, or walker
  • Previous stem cell transplant in the last 6 months
  • Patients with grade 3 or greater sensory/motor neuropathy

Outcomes

Primary Outcomes

Change from Baseline 6-minute walk test at 6 weeks discharge.

Time Frame: Average of 100 days post-transplant

Test of Endurance (Pre-transplant, at discharge, and 6 weeks discharge.)

Change from Baseline Manual Muscle Testing at 6 weeks post discharge

Time Frame: Average of 100 days post-transplant

Muscle strength

WeeFIM

Time Frame: Average of 100 days post-transplant

Change from Baseline Functionality at 6 weeks post discharge.

Secondary Outcomes

  • PROMISE Measures(Average of 100 days post transplant)
  • Time Out of Bed(through study completion, average of 1 year)

Study Sites (1)

Loading locations...

Similar Trials